FIRE Study: Real-World Effectiveness and Safety of Ibrutinib in Clinical Practice in Patients with CLL and MCL

The FIRE study investigated the real-world effectiveness and safety of ibrutinib in prospectively observed patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and mantle cell lymphoma (MCL) in France. Patients were mostly relapsed/refractory with high-risk features. Fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Dartigeas, Caroline, Slama, Borhane, Doyle, Margaret, Tapprich, Christoph, Albrecht, Claire, Dupuis, Sandrine, Wapenaar, Robert, Schmidt-Hieber, Charlotte, Leblond, Veronique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492818/
https://www.ncbi.nlm.nih.gov/pubmed/36103041
http://dx.doi.org/10.1007/s44228-022-00015-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492818/
https://www.ncbi.nlm.nih.gov/pubmed/36103041
http://dx.doi.org/10.1007/s44228-022-00015-5

Ejemplares similares